Netherlands Pharmacovigilance Centre Larebindex medicationmarker medicationADRangiotensin receptor blockerADRsfirst medication
…ed secondary data from spontaneous ADR reports submitted to the Netherlands Pharmacovigilance Centre Lareb between 2019 and 2025. ADR reports were included if the ADR was…